ZILBRYSQ
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for ZILBRYSQ, covering 2023-10-17 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Zilbrysq (zilucoplan) — UCB Pharma S.A.
7 regulatory and trial events tracked for ZILBRYSQ, covering 2023-10-17 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Zilbrysq (zilucoplan) — UCB Pharma S.A.